Molecular and Genetic Analysis of Lung Cancer
| Status: | Recruiting |
|---|---|
| Conditions: | Lung Cancer, Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 9/2/2017 |
| Start Date: | June 1993 |
| End Date: | September 2022 |
| Contact: | David Christiani, MD |
| Email: | dchris@hsph.harvard.edu |
| Phone: | 617-726-9274 |
Investigators use a genome-wide approach within a case-control design to identify SNPs that
show evidence of association with lung cancer risk and survival.
show evidence of association with lung cancer risk and survival.
Investigators also investigate how genetic variants may affect cancer treatment, at various
stages of disease development, in order to determine prognostic and predictive factors for
survival.
stages of disease development, in order to determine prognostic and predictive factors for
survival.
Inclusion Criteria:
- healthy controls: participants without evidence of any cancer
- cases: pathology proven primary lung cancer
Exclusion Criteria:
- younger than 18 years old
We found this trial at
1
site
185 Cambridge Street
Boston, Massachusetts 02114
Boston, Massachusetts 02114
617-724-5200
Phone: 617-726-9274
Click here to add this to my saved trials
